Osteochondral injuries are prevalent and difficult to treat in clinical practice. Traditional tissue engineering typically results in poor integration at the calcified cartilage interlayer, since they cannot address different needs from the cartilage and the supporting subchondral bone. This study presents a hybrid biological scaffold integrating soft and hard components to systematically adopt to osteochondral regeneration. The upper section consists of bioactive hydrogel, kartogenin (KGN), and bone marrow stromal cells (BMSCs), replicating mechanical properties and chondrogenic potential of nature hyaline cartilage. The lower section utilizes a biodegradable metal magnesium (Mg) alloy scaffold with customized porous structure, providing mechanical response comparable to trabecular bone, along with regulated degradation and enhanced angiogenesis and osteogenesis. The bioactive hydrogel is compressed into the pores of Mg scaffold. Notably, the unique combination not only significantly improves mechanical response and fatigue resistance of the cartilage section but also maintains interface stability throughout the repair process. Accordingly, the hybrid scaffold effectively promotes the regeneration of both cartilage and subchondral bone simultaneously by upregulation of osteogenic and chondrogenic specific genes. Overall, this work provides valuable insights for treating osteochondral injuries by material-structure-function integrated strategies.
28 August 2025 in International Journal of Biological Macromolecules
Lactate, as an end product of glycolysis, plays an important role in cellular metabolism and signal transduction, and recent studies have shown that it is closely related to cellular differentiation, but its potential role in osteogenic differentiation has not yet been fully investigated. We obtained two datasets containing human mesenchymal stem cells and human osteoblasts, GSE12266 and GSE18043, from the GEO database, which contained a total of 14 samples with sequencing data, and searched for lactate metabolism-related genes from the Genecards database. Ten differentially expressed core genes related to lactate metabolism were identified by differential expression analysis, protein interaction network analysis, and correlation expression analysis, and determined to play a key role in osteogenic differentiation. The effects of hub genes on the immune microenvironment of osteogenic differentiation were explored by enrichment analysis and immune infiltration analysis, and the significant effects of the key gene TYRO Protein Tyrosine Kinase-Binding Protein(TYROBP) on the characterization of bone marrow mesenchymal stem cells (BMSCs) were experimentally verified, and it was determined by drug sensitivity analysis that TYROBP may be a regulatory target of certain drugs affecting osteogenic differentiation. We successfully screened 10 differentially expressed hub genes related to lactate metabolism, and their area under the curve AUC values for predicting osteogenic differentiation were all highly favorable. Enrichment analysis showed that lactate metabolism may affect osteoblast differentiation through immune infiltration, and the immune infiltration results confirmed the strong association between hub genes and osteoblast immune infiltration status. It was verified that decreasing TYROBP expression promoted cell viability, proliferation and migration ability of BMSCs. Drug sensitivity analysis showed that TYROBP may be a major regulator of drug-induced MSC differentiation. Our study reveals the critical role of lactate metabolism in osteoblast differentiation, identifies the role of the key gene TYROBP in the regulation of BMSCs, and provides new insights for studies related to the regulation of osteoblast differentiation.
Background: Coagulation is an important physiological process for the body to cope with vascular injury, involving platelet activation, coagulation factor cascade reaction and fibrin formation. The role of the coagulation system in inflammatory and degenerative diseases has received increasing attention in recent years. However, its impact for osteoarthritis remains to be well investigated. Methods: The GEO database provided us with microarray data that included osteoarthritis and normal samples. The Genecards database provided coagulation-related genes. Protein interaction network analysis, machine learning, and screening for differentially expressed genes were used to identify coagulation-related core genes relevant to osteoarthritis. Coagulation-related osteoarthritis subtypes were identified by clustering analysis. Enrichment analysis and immune infiltration analysis revealed the potential mechanism of coagulation-related genes promoting osteoarthritis progression. The screened core genes were further validated by chondrocyte experiments. Result: We successfully screened the coagulation-related genes COL3A1 and MMP1 as core genes for osteoarthritis diagnosis. Both nomogram and diagnostic model constructed based on them have excellent diagnostic value, while OA samples can be classified into different subtypes. Immune infiltration study confirmed enrichment analysis’s finding that COL3A1 could affect the course of osteoarthritis by controlling immunological pathways. Basic research confirms that overexpression of COL3A1 inhibits proliferation and viability of chondrocytes and promotes senescence and damage. We confirmed that COL3A1 is an intervention target for osteoarthritis. Conclusion: Our study identifies osteoarthritis subtypes associated with coagulation and reveals the regulatory role of COL3A1 on chondrocytes in inflammatory environment. It offers fresh perspectives on osteoarthritis management.